opens in a new window
Latest News & Media From Quay Pharma
August 26 2022
Careers in the USA at SGS Quay Pharma
Find your next role at SGS Quay Pharma in the USA
Read MoreAugust 26 2022
Careers in the UK at SGS Quay Pharma
Find your next role at SGS Quay Pharma in the UK
Read MoreAugust 08 2022
SGS Quay Pharma Receives Queen’s Award for Industry
SGS Quay Pharma has received its Queen’s Award for Enterprise. The award was presented by...
Read MoreJuly 18 2022
SGS’s Quay Pharma Collaborates to Develop New Oral Medicine for Inflammatory Bowel Disease
SGS’s Quay Pharma has partnered with Intract Pharma, CPI and Pharmidex to successfully...
Read MoreJuly 12 2022
New Hampshire Pharmaceutical Development and Clinical Manufacturing Facility Nears Completion
We will soon open our Hudson, NH, pharmaceutical development and clinical manufacturing facility.
Read MoreApril 08 2022
SGS Quay’s Microbiome Expertise Ideal For New IBD Drug Development Project
SGS Quay Pharma is partnering on a major project to develop and commercialise an inflammatory...
Read MoreDecember 10 2021
Acquisition Will Further Strengthen Quay Offering
Quay Pharma has been acquired by SGS, the Swiss-based world leading (TIC) Testing, Inspection and Certification company.
Read MoreApril 29 2021
Quay Pharma Wins Queen’s Award For Industry
Quay Pharmaceutical has been honoured with a Queen’s Award for Enterprise, the UK’s highest accolade for business success.
Read MoreMarch 22 2021
Now Recruiting in the US
Now Recruiting in the US. We have significantly extended our presence in the United States with the securing of a 55,000 sq ft facility for pharmaceutical development...
Read MoreFebruary 10 2021
Quay Lends its Expertise to Medicines Discovery Catapult Network
Leading pharmaceutical outsourcing specialist Quay Pharma has become the first CDMO (contract development…
Read More
INSPECTED FACILITIES
